02 July 2021

Innov’SA x Nausicaa Médical

Acquisition

Secteur Health

Innov'SA integrates Nausicaa Médical's know-how and positions itself as a leading player in medical equipment for seniors.

Client Innov’SA

Created in 2001, Innov'SA is today the leader in the design and manufacture of seating solutions adapted to an audience of elderly people at home and in institutions. All its products are marketed throughout the French territory, Dom-Tom and Export via a large number of pharmaceutical network wholesalers as well as 2,200 health service stores.

Contrepartie Nausicaa Médical

Led by the Chauzat family for more than 25 years, Nausicaa Medical is a leading player in the design, development and manufacture of ranges of patient-lips, straps and textile belts mainly for the home support of seniors. In addition to its historical ranges, Nausicaa Medical markets medical beds and bedsore prevention mattresses to its 1,500 customers, medical device distributors, large chains and independent specialist stores such as La Centrale Médicale, Harmony medical service, SLK or Bastide Le Confort Médical.

Contrepartie BNP Paribas

BNP Paribas is a French bank, the leading French bank in terms of business and profitability, and the 10th largest international banking group, present in 71 countries. As one of the pillars of the French banking industry, it is listed on the leading Euronext Paris market and is part of the CAC 40 index.

Contrepartie Socadif

Socadif supports SMEs and mid-caps in their development and transmission capital operations.

Innov’SA, managed and majority-owned by Bruce Andurand and François Lessard, is acquiring Nausicaa Medical. The transaction is supported by debt arranged by BNP Paribas. Innov’SA is supported by the Socadif fund.

Created in 2001, Innov’SA is today the leader in the design and manufacture of seating solutions adapted to an audience of elderly people at home and in institutions. All its products are marketed throughout the French territory, Dom-Tom, and exported via a large number of pharmaceutical network wholesalers as well as 2,200 health service stores.

Historically, Innov’SA has enjoyed an excellent reputation for its innovative shell chairs and has been able to complete its range of medical devices with the launch in 2019 of pushchairs. To meet the expectations of senior citizens comprehensively, a comfort range with lifting and resting chairs has been developed by its teams. Aware of its strengths, the company has decided to accelerate this diversification of its medical ranges through external growth.

After a search initiated in December 2020 with the teams of PAX Corporate Finance, Innov’SA chose to acquire Nausicaa Médical.

This acquisition offers numerous synergies between the two companies in terms of complementary product ranges, optimization of internal processes, and integration of new know-how. Nausicaa Médical will add €10 million in sales and a team of 60 employees to Innov’SA, with approximately 20% of its sales generated abroad. The new entity should have sales of around €50 million by 2021.

Objective: To become the build-up platform on the Silver economy market
In order to accelerate its growth, Innov'SA's ambition is to provide a global response to seniors with a wide range of medical equipment. This ambition involves intensifying its international sales, studying new distribution channels and new acquisition opportunities.